Capricor Therapeutics Inc
(NASDAQ:CAPR)
$3.67
0.25[7.31%]
Last update: 7:57PM (Delayed 15-Minutes)
Get Real Time Here
$3.67
0[0.00%]
After-Hours
Open3.400Close3.690
Vol / Avg.241.880K / 245.480KMkt Cap113.010M
Day Range3.375 - 3.70052 Wk Range2.680 - 8.221

Capricor Therapeutics Stock (NASDAQ:CAPR), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$40.00

Lowest Price Target1

$15.00

Consensus Price Target1

$27.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
20000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Ladenburg Thalmann

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Capricor Therapeutics

Upgrades (0)

Downgrades (0)

Initiations (1)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
10/04/2023CAPRBuy Now
Capricor Therapeutics
$3.67989.92%HC Wainwright & Co.
Joseph Pantginis
$18 → $40MaintainsBuyGet Alert
08/15/2023CAPRBuy Now
Capricor Therapeutics
$3.67390.46%HC Wainwright & Co.
Joseph Pantginis
→ $18ReiteratesBuy → BuyGet Alert
03/16/2023CAPRBuy Now
Capricor Therapeutics
$3.67390.46%HC Wainwright & Co.
Joseph Pantginis
→ $18Reiterates → BuyGet Alert
10/26/2022CAPRBuy Now
Capricor Therapeutics
$3.67308.72%Ladenburg Thalmann
Aydin Huseynov
→ $15Initiates → BuyGet Alert
01/31/2022CAPRBuy Now
Capricor Therapeutics
$3.67390.46%HC Wainwright & Co.
Joseph Pantginis
$14 → $18MaintainsBuyGet Alert
10/11/2021CAPRBuy Now
Capricor Therapeutics
$3.67281.47%HC Wainwright & Co.
Joseph Pantginis
MaintainsBuyGet Alert
Q

What is the target price for Capricor Therapeutics (CAPR)?

A

The latest price target for Capricor Therapeutics (NASDAQ: CAPR) was reported by HC Wainwright & Co. on October 4, 2023. The analyst firm set a price target for $40.00 expecting CAPR to rise to within 12 months (a possible 989.92% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Capricor Therapeutics (CAPR)?

A

The latest analyst rating for Capricor Therapeutics (NASDAQ: CAPR) was provided by HC Wainwright & Co., and Capricor Therapeutics maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Capricor Therapeutics (CAPR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Capricor Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Capricor Therapeutics was filed on October 4, 2023 so you should expect the next rating to be made available sometime around October 4, 2024.

Q

Is the Analyst Rating Capricor Therapeutics (CAPR) correct?

A

While ratings are subjective and will change, the latest Capricor Therapeutics (CAPR) rating was a maintained with a price target of $18.00 to $40.00. The current price Capricor Therapeutics (CAPR) is trading at is $3.67, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.